A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 10, 2009, Pages 1303-1314

  Marcu, Loredana G ^a,b   Yeoh, E ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF ORADEA   (Romania)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Cisplatin; Genetics; Head and neck; Pathology; Radiotherapy; Risk factors

Indexed keywords

AMINOLEVULINIC ACID; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; GEMCITABINE; MITOMYCIN C; OXALIPLATIN; PACLITAXEL; PROTEIN P53; TIRAPAZAMINE;

ALCOHOL CONSUMPTION; BRACHYTHERAPY; CANCER GROWTH; CANCER RISK; CANCER SURGERY; CARCINOGENESIS; CIGARETTE SMOKING; COLORECTAL CANCER; DRUG WITHDRAWAL; EPIGENETICS; GENE INTERACTION; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC RISK; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; INTENSITY MODULATED RADIATION THERAPY; LARYNX CANCER; MOUTH CANCER; NOSE CANCER; OROPHARYNX CARCINOMA; PARANASAL SINUS CANCER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; REVIEW; RISK ASSESSMENT; SALIVARY GLAND CANCER; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

GENETIC VARIATION; HEAD AND NECK NEOPLASMS; HUMANS; RISK FACTORS;

EID: 69049089826     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0648-7     Document Type: Review

References (84)

1. L Ai KK Stephenson W Ling C Zuo P Mukunyadzi, et al. 2003 The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases Mod Pathol 16 944 950 10.1097/01.MP.0000085760.74313.DD
2. M Al-Sarraf T Pajak V Marcial, et al. 1987 Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG study Cancer 59 259 265 10.1002/1097-0142(19870115)59: 2<259::AID-CNCR2820590214>3.0.CO;2-1
3. F Arias M Dominguez J Illarramendi, et al. 1995 Split hyperfractionated accelerated radiation therapy and concomitant cisplatin for locally advanced head and neck carcinomas: a preliminary report Int J Radiat Oncol Biol Phys 33 675 682 10.1016/0360-3016(95)00210-P
4. JW Bailet E Abemayor BA Jabour RA Hawkins, et al. 1992 Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy Laryngoscope 102 281 288
5. GK Beckmann F Hoppe L Pfreundner MP Flentje 2005 Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer Head Neck 27 36 43 10.1002/hed.20111
6. GC Bedi WH Westra E Gabrielson, et al. 1996 Multiple head and neck tumors: evidence for a common clonal origin Cancer Res 56 2484 2487
7. F Berrino L Richiardi P Boffetta J Esteve, et al. 2003 Occupation and larynx and hypopharynx cancer: a job-exposure matrix approach in an international case-control study in France, Italy, Spain and Switzerland Cancer Causes Control 14 213 223 10.1023/A:1023661206177
8. JA Bonner PM Harari J Giralt N Azarnia, et al. 2006 Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 567 578 10.1056/NEJMoa053422
9. DM Brizel 1998 Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma Semin Radiat Oncol 8 237 246 10.1016/S1053-4296(98)80021-0
10. G Browman I Hodson R Mackenzie N Bestic L Zuraw 2001 Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis Head Neck 20 579 589 10.1002/hed.1081
11. Califano J, van der RP, Westra W et al (1996) Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56:2488-2492
12. LS Caplan HI Hall RS Levine K Zhu, et al. 2000 Preventable risk factors for nasal cancer Ann Epidemiol 10 186 191 10.1016/S1047-2797(99)00049-6
13. AM Chen MK Bucci JM Quivey J Garcia, et al. 2006 Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas Int J Radiat Oncol Biol Phys 66 1044 1050 10.1016/j.ijrobp.2006.06.050
14. JJ Closmann 2007 The human papilloma virus, the vaccines, and oral and oropharyngeal squamous cell carcinoma: what every dentist should know Gen Dent 55 3 252 254
15. E Creagan J O'Fallon J Woods, et al. 1983 Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancer Cancer 51 2020 2023 10.1002/1097-0142(19830601)51: 11<2020::AID-CNCR2820511110>3.0.CO;2-X
16. JG Douglas GE Laramore M Austin-Seymour WJ Koh, et al. 1996 Neutron radiotherapy for adenoid cystic carcinoma of minor salivary glands Int J Radiat Oncol Biol Phys 36 87 93 10.1016/S0360-3016(96)00213-1
17. KF Fan C Hopper PM Speight G Buonaccorsi, et al. 1996 Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity Cancer 78 1374 1383 10.1002/(SICI)1097-0142(19961001)78: 7<1374::AID-CNCR2>3.0.CO;2-L
18. VJ Feron JH Arts CF Kuper PJ Slootweg, et al. 2001 Health risks associated with inhaled nasal toxicants Crit Rev Toxicol 31 313 347 10.1080/20014091111712
19. U Fisch 1983 The infratemporal fossa approach for nasopharyngeal tumors Laryngoscope 93 36 44
20. U Fisch P Fagan A Valvanis 1984 The infratemporal fossa approach for the lateral skull base Otolaryngol Clin North Am 17 513 552
21. J Fontanesi NS Beckford EP Lester, et al. 1991 Concomitant cisplatin and hyperfractionated external beam irradiation for advanced malignancy of the head and neck Am J Surg 162 393 396 10.1016/0002-9610(91)90156-8
22. KK Fu 1998 Combined radiotherapy and chemotherapy for nasopharyngeal carcinoma Semin Radiat Oncol 8 247 253 10.1016/S1053-4296(98)80022-2
23. L Gallicchio G Matanoski XG Tao L Chen, et al. 2006 Adulthood consumption of preserved and nonpreserved vegetables and the risk of nasopharyngeal carcinoma: a systematic review Int J Cancer 119 1125 1135 10.1002/ijc.21946
24. AS Garden J Harris A Trotti CU Jones, et al. 2008 Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14) Int J Radiat Oncol Biol Phys 71 1351 1355 10.1016/j.ijrobp.2008.04.006
25. G Gasparini F Pozza G Recher, et al. 1991 Simultaneous cis-platinum and radiotherapy in inoperable or locally advanced squamous cell carcinoma of the head and neck Oncology 48 270 276
26. L Gleich J Ryzenman J Gluckman K Wilson, et al. 2004 Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible? Arch Otolaryngol Head Neck Surg 130 35 38 10.1001/archotol.130.1.35
27. SR Go AA Adjei 1999 Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin J Clin Oncol 17 1 409 422
28. WE Grant C Hopper PM Speight AJ Macrobert, et al. 1993 Photodynamic therapy of malignant and premalignant lesions in patients with 'field cancerization' of the oral cavity J Laryngol Otol 107 1140 1145 10.1017/S0022215100125496
29. KM Greven DW Williams JW Keyes Jr WF McGuirt, et al. 1994 Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation Cancer 74 1355 1359 10.1002/1097-0142(19940815)74: 4<1355::AID-CNCR2820740428>3.0.CO;2-I
30. D Han ZG Huang W Zhang ZK Yu, et al. 2003 Effectiveness of recombinant adenovirus p53 injection on laryngeal cancer: phase I clinical trial and follow up Chin J Cancer Res 83 2029 2032
31. D Hardisson 2003 Molecular pathogenesis of head and neck squamous cell carcinoma Eur Arch Otorhinolaryngol 260 502 508 10.1007/s00405-003-0581-3
32. R Herrero X Castellsague J Plissowska, et al. 2003 Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study J Natl Cancer Inst 95 1772 1783
33. BS Hoppe LD Stegman MJ Zelefsky KE Rosenzweig, et al. 2007 Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting-the MSKCC experience Int J Radiat Oncol Biol Phys 67 691 702 10.1016/j.ijrobp.2006.09.023
34. C Jacobs JR Bertino DR Goffinet, et al. 1978 24-hour infusion of cis-platinum in head and neck cancers Cancer 42 2135 2140 10.1002/1097- 0142(197811)42:5<2135::AID-CNCR2820420508>3.0.CO;2-W
35. B Jeremic Y Shibamoto B Milicic, et al. 2000 Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial J Clin Oncol 18 1458 1464
36. M Julieron S Temam 2004 Locoregional recurrence of ORL cancer: the place of surgery Bull Cancer 91 863 869
37. GJ Kalyankrishna 2006 Epidermal growth factor receptor biology in head and neck cancer J Clin Oncol 17 2666 2672 10.1200/JCO.2005.04.8306
38. K Kato A Hara T Kuno H Mori, et al. 2006 Aberrant promoter hypermethylation in oral squamous cell carcinomas and the surrounding normal mucosa J Cancer Res Clin Oncol 132 735 743 10.1007/s00432-006-0122-8
39. TS Katz WM Mendenhall CG Morris RJ Amdur, et al. 2002 Malignant tumors of the nasal cavity and paranasal sinuses Head Neck 24 821 829 10.1002/hed.10143
40. Kawashiri S, Noguchi N, Tanaka A, Nakaya H et al (2009) Inhibitory effect of neoadjuvant chemotherapy on metastasis of oral squamous cell carcinoma in a mouse model. Oral Oncol
41. Kim AJ, Suh JD, Sercarz JA, Abemayor E et al (2007) Salvage surgery with free flap reconstruction: factors affecting outcome after treatment of recurrent head and neck squamous carcinoma. Laryngoscope 117:1019:23
42. SI Kvaal T Warloe 2007 Photodynamic treatment of oral lesions J Environ Pathol Toxicol Oncol 26 127 133
43. TS Lawrence AW Blackstock C McGinn 2003 The mechanism of action of radiosensitization of conventional chemotherapeutic agents Semin Radiat Oncol 13 1 13 21 10.1053/srao.2003.50002
44. B Leipzig 1983 Cisplatin sensitization to radiotherapy of squamous cell carcinomas of the head and neck Am J Surg 146 462 465 10.1016/0002-9610(83) 90231-3
45. F Lewin SE Norell H Johansson P Gustavsson, et al. 1998 Smoking tobacco, oral snuff, and alcohol in the aetiology of squamous cell carcinoma of the head and neck Cancer 82 1367 1375 10.1002/(SICI)1097-0142(19980401)82:7<1367::AID- CNCR21>3.0.CO;2-3
46. S Lonn A Ahlbom HC Christensen C Johansen, et al. 2006 Mobile phone use and risk of parotid gland tumor Am J Epidemiol 164 637 643 10.1093/aje/kwj242
47. M Majem R Mesia M Mañós J Gomez, et al. 2006 Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma Laryngoscope 116 1651 1656 10.1097/01.mlg.0000231736.08477.47
48. JL Marchand D Luce A Leclerc P Goldberg, et al. 2000 Laryngeal and hypopharyngeal cancer and occupational exposure to asbestos and man-made vitreous fibers: results of a case-control study Am J Ind Med 37 581 589 10.1002/(SICI)1097-0274(200006)37:6<581::AID-AJIM2>3.0.CO;2-D
49. L Marcu T van Doorn I Olver 2003 Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer Acta Oncol 42 4 315 325 10.1080/02841860310004364
50. JA Medina A Rueda AS de Pasos J Contreras, et al. 2006 A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas Radiother Oncol 79 34 38 10.1016/j.radonc.2006.03.010
51. Menvielle G, Luce D, Goldberg P, Bugel I et al (2004) Smoking, alcohol drinking and cancer risk for various sites of the larynx and hypopharynx. A case-control study in France. Eur J Cancer Prev 13:165-172. doi: 10.1097/01.cej.0000130017.93310.76
52. L Milas K Mason Z Liao K Ang 2003 Chemoradiotherapy: emerging treatment improvement strategie Head Neck 25 152 167 10.1002/hed.10232
53. Mould R (1993) A century of X-rays and radioactivity in medicine. Institute of Physics Publishing, Bristol
54. JM Nauta HL van Leengoed WM Star JL Roodenburg, et al. 1996 Photodynamic therapy of oral cancer A review of basic mechanisms and clinical applications. Eur J Oral Sci 104 69 81 10.1111/j.1600-0722.1996.tb00049.x
55. G Novacek 2006 Plummer-Vinson syndrome Orphanet J Rare Dis 15 1 36
56. K Nylander E Dabelsteen PA Hall 2000 The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck J Oral Pathol Med 29 413 425 10.1034/j.1600-0714.2000.290901.x
57. A Olshan M Weissler H Pei K Conway 1997 p53 Mutations in head and neck cancer: new data and evaluation of mutational spectra Cancer Epidemiol Biomarkers Prev 6 499 504
58. J Overgaard HS Hansen L Specht M Overgaard, et al. 2003 Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial Lancet 362 933 940 10.1016/S0140-6736(03)14361-9
59. A Pandor S Eggington S Paisley P Tappenden P Sutcliffe 2006 The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation Health Technol Assess 10 1 204
60. L Perea-Milla RM Minarro-Del Moral C Martinez-Garcia R Zanetti, et al. 2003 Lifestyles, environmental and phenotypic factors associated with lip cancer: a case-control study in southern Spain Br J Cancer 88 1702 1707 10.1038/sj.bjc.6600975
61. B Perez-Ordoňez M Beauchemin RC Jordan 2006 Molecular biology of squamous cell carcinoma of the head and neck J Clin Pathol 59 445 453 10.1136/jcp.2003.007641
62. LJ Peters HR Withers 1997 Applying radiobiological principles to combined modality treatment of head and neck cancer-the time factor Int J Radiat Oncol Biol Phys 39 831 836 10.1016/S0360-3016(97)00466-5
63. KT Robbins P Kumar W Regine, et al. 1997 Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience Int J Radiat Oncol Biol Phys 38 263 271 10.1016/S0360-3016(97)00092-8
64. K Rosenquist 2005 Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden Swed Dent J Suppl 179 1 66
65. K Sako MS Razack I Kalnins 1978 Chemotherapy for advanced and recurrent squamous cell carcinoma of the head and neck with high and low dose cis-diamminedichloroplatinum Am J Surg 136 529 533 10.1016/0002-9610(78)90276-3
66. M Sanchez-Cespedes M Esteller L Wu H Nawroz-Danish, et al. 2000 Gene promoter hypermethylation in tumors and serum of head and neck cancer patients Cancer Res 60 892 895
67. R Sankaranarayanan E Masuyer R Swaminathan J Ferlay S Whelan 1998 Head and neck cancer: a global perspective on epidemiology and prognosis Anticancer Res 18 4779 4786
68. SP Schantz Q Huang K Shah VV Murty, et al. 2000 Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers Carcinogenesis 21 1239 1246 10.1093/carcin/21.6.1239
69. R Scher R Esclamado 2009 Organ and function preservation: the role of surgery as the optimal primary modality or as salvage after chemoradiation failure Semin Radiat Oncol 19 17 23 10.1016/j.semradonc.2008.09.004
70. DE Schuller E Ozer A Agrawal JC Grecula, et al. 2007 Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience Arch Otolaryngol Head Neck Surg 133 320 326 10.1001/archotol.133.4. 320
71. E Seifert A Schadel U Haberkorn LG Strauss 1992 Evaluating the effectiveness of chemotherapy in patients with head-neck tumors using positron emission tomography (PET scan) Head Neck Oncol 40 90 93
72. M Serin HS Erkal A Cakmak 1999 Radiation therapy and concurrent cisplatin in management of locoregionally advanced nasopharyngeal carcinomas Acta Oncol 38 1031 1035 10.1080/028418699432310
73. O Shangina P Brennan N Szeszenia-Dabrowska D Mates, et al. 2006 Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe Am J Epidemiol 164 367 375 10.1093/aje/kwj208
74. MH Shirinian RS Weber SM Lippman IW Dimery, et al. 1994 Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M D. Anderson Cancer Center experience. Head Neck 16 39 44 10.1002/hed.2880160109
75. DP Slaughter HW Southwick 1953 "Field cancerization" in oral stratified squamous epithelium Clinical implications of multicentric origin. Cancer 6 963 968 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0. CO;2-Q
76. EM Sturgis BA Moore BS Glisson MS Kies, et al. 2005 Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case series Head Neck 27 748 756 10.1002/hed.20240
77. B Vikram EW Strong JP Shah, et al. 1984 Failure at distant sites following multimodality treatment for advanced head and neck cancer Head Neck Surg 6 730 733 10.1002/hed.2890060305
78. Vivek RS, Baludavid M, Mohanram R, Chitra et al (2006) Concurrent chemo-irradiation using accelerated concomitant boost radiation therapy in loco-regionally advanced head and neck squamous cell carcinomas. J Cancer Res Ther 2:90-96
79. Q Wang Z Wu D Han W Zhang, et al. 1999 Growth inhibition of human laryngeal cancer cell with the adenovirus-mediated p53 gene Chin J Cancer Res 11 157 160
80. A Yoshikawa R Saura T Matsubara 1997 A mechanism of cisplatin action: antineoplastic effect through inhibition of neovascularization Kobe J Med Sci 43 109 120
81. LS Young CW Dawson D Clark H Rupani, et al. 1988 Epstein-Barr virus gene expression in nasopharyngeal carcinoma J Gen Virol 69 1051 1065 10.1099/0022-1317-69-5-1051
82. 2 gene in head and neck carcinogenesis Clin Cancer Res 10 1733 1742 10.1158/1078-0432.CCR-0989-3
83. JM Yuan XL Wang YB Xiang YT Gao, et al. 2000 Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China Int J Cancer 85 358 363 10.1002/(SICI)1097-0215(20000201)85:3<358::AID-IJC11>3.0.CO;2-E
84. W Yuen M Man K Lam Y Kwong 2002 Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas J Clin Pathol 55 58 60